✦ LIBER ✦

Daily interferon alpha 2b and Ribavirin combination therapy for chronic hepatitis C patients who have relaped or not responded to previous treatment: One year treatment results

✍ Scribed by Karasu, Zeki; Gurakar, Ahmet O.; Jazzar, Ahmad S.; Emmett, Carolyn; McMillon, Greg C.; Nour, Bakr M.; Wright, Harlan I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daily use of consensus interferon for ch

✍ Karasu, Zeki; Gurakar, Ahmet O.; Jazzar, Ahmad S.; Emmett, Carolyn; Hulagu, Saad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Combination treatment with interferon al

✍ Birdi, Parvinder K.; Wustrack, Sonja; Rostetter, Elizabeth; King, John W.; Balar 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Daily or three times per week interferon

✍ Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Pierre-Henri Bernard; Mar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Retreatment with pegylated interferon-al

✍ Teuber, Gerlinde; Kallinowski, Birgit; Niederau, Claus; Klinker, Hans; Galle, Pe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Intravenous Recombinant Interferon-Beta

✍ G. Barbaro, G. Di Lorenzo, M. Soldi, 📂 Article 📅 1999 🏛 Informa plc 🌐 English ⚖ 84 KB

Treatment of hepatitis C with daily indu

✍ Lawitz, Eric J.; Kadakia, Shailesh C.; Cantu, Norma; Nader, Pierre; Cox, James; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB